ASG Eye Hospitals, backed by General Atlantic and Kedaara Capital, has agreed to a ₹450 crore non-binding merger with Sharp Sight Eye Hospitals. This deal, valued at ₹7,000 crore for ASG, will see Sharp Sight's founder and management receive ASG shares, while investor InvAscent will get cash.